Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House committee debates MOUD bill: members split over scope, data and private contractor role
Summary
Committee members spent April 24 debating a bill that codifies continuity-of-care rules for medication for opioid use disorder (MOUD) in correctional facilities, clarifies reentry procedures, and allows DOC to consider injectable formulations if funded.
Committee members spent the bulk of the April 24 meeting on a bill that would codify and clarify the Department of Corrections’ medication for opioid use disorder (MOUD) practices inside correctional facilities and at reentry.
Lede and what it would do
Committee members heard that the MOUD program was established in corrections in about 2017–2018 and that this bill primarily cleans up statutory language and codifies practices the Department of Corrections (DOC) and its contractor already perform: continuing MOUD during incarceration, arranging appointments with community “hubs” for reentry, and ensuring detainees leave with enough medication to bridge until a community appointment. The sponsor said the bill does not create the MOUD program or repeal it; it “tidies” statutory language and allows DOC to use newer delivery forms such as injectable formulations if appropriations permit.
Why it matters
Members framed the bill as a continuity-of-care measure for people in custody: supporters said consistent treatment reduces overdose and supports reentry, while opponents…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
